Privacy preference

MEDtalks would like to keep you informed about the content that is most relevant to you. Click here for more information.

Congresnieuws 14/11/2018

Euretina 2018: News

This Euretina highlight brings you news about: * profilactic laser in AMD * first results of the ALTAIR study and the ARIES study * Elaboration on the PROTOCOL S and CLARITY studies

Congresnieuws 14/11/2018

Euretina 2018: Important developments

This Euretina Highlight brings you news about: * developments after the presentation of the PLACE trial results . * How will eye diseases being diagnosed in the future? * The importance of OCT in CSC. * Neovaslularization and PCV in CSC.

Congresnieuws 22/03/2018

WCM 2017 Highlights: Immunotherapy

The 9th World Congress of Melanoma (WCM) was held in Brisbane, Australia, from 18 to 21 October. In a series of interviews medical professionals from all over the world discussed the latest developments in the field of melanoma. This highlight consists of the following parts: Prof. Caroline Robert, MD – dermatologist, Institute Gustave-Roussy, Paris, France: The latest results of immunotherapy in melanoma Alain Algazi, MD – oncologist, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA: Clinical immune monitoring and biomarker data of pIL-12 monotherapy compared to pIL-12 with pembrolizumab in metastatic melanoma Sapna Patel, MD – oncologist, MD Anderson Cancer Center, Houston, USA: A phase II study of glembatumumab vedotin for metastatic uveal melanoma